None listed
Conditions
Interventions
Medical Device : Test group: group injecting deep body cavity wound dressings into the urethra using a urethral catheter
After surgery, using the urethral catheter for clinical trials, the drug is in
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Patients scheduled to undergo transurethral bladder tumor removal,aged >=18 and <80 years
Exclusion criteria
Exclusion criteria: 1) Patients who have participated in other clinical trials within 1 month prior to being registered for clinical trial and have received drug administration or medical device treatment 2) Those with congenital abnormalities in the urinary or reproductive system 3) If you have neurogenic bladder disease 4) If you have had a previous radical prostatectomy for prostate cancer 5) Those with a history of allergy or hypersensitivity to substances and catheter used to prevent urethral strictures 6) There is dermatitis in catheterization 7) People with immunodeficiency diseases (eg, HIV-infected) 8) People with blood clotting disorders 9) A person who is inappropriate to participate in a clinical trial because the investigator judges it to be other ethically or because it may affect the clinical trial results
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| user convenience (Likert Scale Degree of Satisfaction Questionnaire) | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analog scale (VAS) ; operator's convenience (Likert Scale);Evaluating the rate of urethral stricture through cystourethral endoscopy | — |
Countries
Korea, Republic of
Contacts
Public ContactDalsan You
Asan Medical Center
Outcome results
None listed